Aurora Cannabis Jumps On Deal To Enter U.S. Retail CBD Market While Rivals Balk
Aurora Cannabis stock spiked yet again late Wednesday after the Canadian pot producer announced an acquisition to enter the U.S. retail CBD market for the first time — even as rivals lament the lack of clarity surrounding regulations of the substance. Other marijuana stocks rose late too.
After the close, Aurora Cannabis (ACB) said it would buy Reliva, a CBD retail brand in the U.S., in an all-stock deal. Reliva will get around $40 million of Aurora Cannabis stock. The deal also includes a possible earn-out — or an arrangement for future payments depending on how well the deal goes —
Comments
Post a Comment